KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Canopy Growth (CGC) Cash & Equivalents (2017 - 2025)

Canopy Growth's Cash & Equivalents history spans 8 years, with the latest figure at $115.9 million for Q4 2024.

  • For Q4 2024, Cash & Equivalents rose 10.54% year-over-year to $115.9 million; the TTM value through Dec 2024 reached $115.9 million, up 10.54%, while the annual FY2024 figure was $85.7 million, 46.02% down from the prior year.
  • Cash & Equivalents for Q4 2024 was $115.9 million at Canopy Growth, down from $167.4 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $972.0 million in Q1 2020 and bottomed at $85.7 million in Q1 2024.
  • The 5-year median for Cash & Equivalents is $418.8 million (2023), against an average of $418.7 million.
  • The largest annual shift saw Cash & Equivalents soared 97.17% in 2021 before it plummeted 76.21% in 2023.
  • A 5-year view of Cash & Equivalents shows it stood at $632.8 million in 2020, then dropped by 22.88% to $488.0 million in 2021, then fell by 9.71% to $440.6 million in 2022, then tumbled by 76.21% to $104.9 million in 2023, then grew by 10.54% to $115.9 million in 2024.
  • Per Business Quant, the three most recent readings for CGC's Cash & Equivalents are $115.9 million (Q4 2024), $167.4 million (Q3 2024), and $140.5 million (Q2 2024).